Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0320
+0.0020 (6.67%)
Sep 4, 2026, 3:58 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 3.73 million as of September 4, 2026. Its market cap has decreased by -63.08% in one year.
Market Cap
3.73M
Enterprise Value
13.18M
Revenue
161.19K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 3.73M, an increase of 19.70%. That is a compound annual growth rate of 1.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.73M | -36.07% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syntara | 51.01M |
| IDT Australia | 19.66M |
| Peak Processing | 18.60M |
| Vitura Health | 17.89M |
| ECS Botanics Holdings | 9.58M |
| Epsilon Healthcare | 8.95M |
| Cann Group | 8.30M |
| Percheron Therapeutics | 7.61M |